Filing Details
- Accession Number:
- 0001127602-24-024682
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-01 16:13:21
- Reporting Period:
- 2024-09-27
- Accepted Time:
- 2024-10-01 16:13:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643934 | Dagmar Rosa-Bjorkeson | C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-09-27 | 2,503 | $20.68 | 8,490 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale was pursuant to a 10b5-1 plan arranged to cover withholding taxes upon vesting of restricted stock units.
Billionaire Hedge Funds
